Evaluation of Systemic Microcirculation of Patients Undergoing Heart Valve Surgery
1 other identifier
observational
31
1 country
1
Brief Summary
The study aims to study the systemic microcirculation in adult patients hospitalized at a quaternary public hospital during the preoperative and immediate postoperative periods of heart valve surgery and correlations to their clinical and laboratory outcomes in the postoperative period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2022
CompletedFirst Submitted
Initial submission to the registry
January 17, 2023
CompletedFirst Posted
Study publicly available on registry
February 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedMay 21, 2025
May 1, 2025
2 years
January 17, 2023
May 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of systemic microcirculation
Number of capillaries in the sublingual microcirculation.
Change of microvascular density between the preoperative and up to four hours in the postoperative period.
Interventions
The 'Cytocam' is a hand held computer-controlled device, a third generation video-microscope, which enables real time visualisation of the in vivo microcirculation, based upon the principle of incident dark field (IDF) illumination.
Eligibility Criteria
Patients scheduled to heart valve surgery under cardiopulmonary bypass.
You may qualify if:
- Patients scheduled to heart valve surgery under cardiopulmonary bypass.
You may not qualify if:
- Patients operated on for infective endocarditis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Cardiology
Rio de Janeiro, 21040-360, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior researcher
Study Record Dates
First Submitted
January 17, 2023
First Posted
February 14, 2023
Study Start
September 10, 2022
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
May 21, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share